Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
gilead sciences
3
×
indiana blog main
3
×
indiana top stories
life sciences
national
national blog main
3
×
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
3
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
amgen
astrazeneca
biogen
boston top stories
cancer
cancer immunotherapy
covid-19
cystic fibrosis
What
acquisitions
3
×
bio
ceo
roundup
biggest
daniel
drug
gilead
o’day
sciences
albert
announced
bourla
build
buy
collabs
company
company’s
covid
crispr
deal
debut
dyne’s
future
gilead’s
help
imports
introduce
ipo
maker
maps
measured
medicines
microbiome
month
moves
openly
patients
pfizer
pfizer’s
Language
unset
unknown
Current search:
acquisitions
×
startups
×
" gilead sciences "
×
" national blog main "
×
" indiana blog main "
×
abbvie
×
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More